Drug Interactions Database

1418 interactions from BNF 85 - Check your medicines

Source: BNF 85

Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916

erythromycin propafenone

increases exposure

Moderate Study

erythromycin rifabutin

increases concentration

Moderate Theoretical

erythromycin rifamycins

increases concentration

Moderate Theoretical

erythromycin sirolimus

increases concentration

Moderate Study

erythromycin statins

increases exposure

Moderate Study

erythromycin temsirolimus

increases concentration

Moderate Theoretical

erythromycin tezacaftor

increases exposure

Moderate Study

erythromycin zopiclone

increases exposure

Moderate Study

eslicarbazepine atorvastatin

decreases exposure

Moderate Theoretical

eslicarbazepine statins

decreases exposure

Moderate Theoretical

etravirine atorvastatin

decreases exposure

Moderate Study

etravirine fluvastatin

increases exposure

Moderate Theoretical

etravirine osimertinib

decreases exposure

Moderate Theoretical

etravirine phosphodiesterasetype-

decreases exposure

Moderate Study

etravirine simvastatin

decreases exposure

Moderate Theoretical

etravirine statins

decreases exposure

Moderate Study

etravirine statins

increases exposure

Moderate Theoretical

fedratinib alfentanil

increases exposure

Moderate Theoretical

fedratinib atomoxetine

increases exposure

Moderate Theoretical

fedratinib benzodiazepines

increases exposure

Moderate Study

fedratinib betablockers,selective

increases exposure

Moderate Study

fedratinib eliglustat

increases exposure

Moderate Theoretical

fedratinib ergotamine

increases exposure

Moderate Theoretical

fedratinib everolimus

increases exposure

Moderate Theoretical

fedratinib metoprolol

increases exposure

Moderate Study

fedratinib midazolam

increases exposure

Moderate Study

fedratinib nebivolol

increases exposure

Moderate Theoretical

fedratinib omeprazole

increases exposure

Moderate Study

fedratinib opioids

increases exposure

Moderate Theoretical

fedratinib oral

increases exposure

Moderate Theoretical

fedratinib protonpumpinhibitors

increases exposure

Moderate Study

fedratinib sirolimus

increases exposure

Moderate Theoretical

fedratinib temsirolimus

increases exposure

Moderate Theoretical

fenofibrate fluvastatin

increases risk of rhabdomyolysis

Moderate Theoretical

fenofibrate statins

increases risk of rhabdomyolysis

Moderate Theoretical

fibrates coumarins

increases anticoagulant effect

Moderate Study

fibrates fluvastatin

increases risk of rhabdomyolysis

Moderate Theoretical

fibrates phenindione

increases anticoagulant effect

Moderate Study

fluconazole antiepileptics

increases concentration

Moderate Study

fluconazole atorvastatin

increases exposure

Moderate Anecdotal

fluconazole coumarins

increases anticoagulant effect

Moderate Study

fluconazole fosphenytoin

increases concentration

Moderate Study

fluconazole phenytoin

increases concentration

Moderate Study

fluconazole rifabutin

increases risk of uveitis

Moderate Study

fluconazole rifamycins

increases risk of uveitis

Moderate Study

fluconazole ruxolitinib

increases exposure

Moderate Theoretical

fluconazole simvastatin

increases exposure

Moderate Anecdotal

fluconazole statins

increases exposure

Moderate Anecdotal

fluorouracil antiepileptics

increases concentration

Moderate Anecdotal

fluorouracil fosphenytoin

increases concentration

Moderate Anecdotal

Prev 1 ... 10 11 12 13 14 ... 29 Next

1418 interactions

Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.